Pittsburgh Alliance, Amazon drive AI product development in Steel City

A large health data-sharing consortium based in Pittsburgh is bringing in Amazon Web Services to help drive research and product development around machine learning and cloud computing in numerous areas of healthcare.

The Pittsburgh Health Data Alliance (PHDA) announced the arrangement Aug. 7, saying scientists from PHDA member institutions—namely the University of Pittsburgh and Carnegie Mellon—will leverage AWS support to accelerate AI activity in cancer risk scoring, mental healthcare, diagnostic accuracy and other concentrations.

For example, a research team led by U of Pitt bioengineer David Vorp, PhD, is developing an algorithm that will guide surgeries for abdominal aortic aneurysms performed before symptoms show up.

The PHDA’s membership also includes the 40-hospital UPMC integrated health system.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.